Entrectinib in Patients with ROS1 Fusion-Positive (ROS1-fp) NSCLC: Updated Efficacy and Safety Analysis
Refereed conference paper presented and published in conference proceedings
Full Text
Digital Object Identifier (DOI) DOI for CUHK Users View Full-text in Publisher Website |
Altmetrics Information
.
Other information
All Author(s) ListFan Y, Drilon A, Chiu CH, Bowles DW, Loong HHF, Siena S, Goto K, Krzakowski M, Ahn MJ, Murakami H, Dziadziuszko R, Zeuner H, Pitcher B, Cheick D, Krebs MG
Name of ConferenceWCLC 2022
Start Date of Conference06/08/2022
End Date of Conference09/08/2022
Place of ConferenceVienna
Country/Region of ConferenceAustria
Journal nameJournal of Thoracic Oncology
Proceedings TitleJournal of Thoracic Oncology
Title of PublicationJOURNAL OF THORACIC ONCOLOGY
Year2022
Month9
Volume Number17
Issue NumberSuppl. 9
PublisherELSEVIER SCIENCE INC
Pages89 - 90
ISSN1556-0864
eISSN1556-1380
LanguagesEnglish-United Kingdom
KeywordsROS1 fusions, NSCLC, Entrectinib
Web of Science Subject CategoriesOncology;Respiratory System;Oncology;Respiratory System
